On February 18, 2021 Mirati Therapeutics, Inc. (NASDAQ: MRTX), a late-stage targeted oncology company, reported that it will participate in two upcoming healthcare conferences (Press release, Mirati, FEB 18, 2021, View Source [SID1234575297]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Friday, February 26th at 12:00 p.m. EST/9:00 a.m. PST at the 10th Annual SVB Leerink Global Healthcare Conference. Dan Faga, executive vice president and chief operating officer will represent Mirati in a fireside chat at the conference.
Wednesday, March 3rd at 2:00 p.m. EST/11:00 a.m. PST at the 41st Annual Cowen Healthcare Conference. Charles M. Baum, M.D., Ph.D., president and chief executive officer will represent Mirati in a fireside chat at the conference.
The webcast will be available through the "Investors" section of the Mirati website, Mirati Investor Events and Presentations, and a replay of the webcast will be made available for 90 days following the event.